Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pédro Raro"'
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, Philippe Gabelle, Julia Pernaut, Francesco Del Piano, Gauthier D’Halluin, Stéphane Lantheaume, Emile Darai, Bassoodéo Beedassy, Caroline Dhainaut-Speyer, Xavier Martin, Sophie Girard, Richard Villet, Emilie Monrigal, Théophile Hoyek, Jean-François Le Brun, Pierre-Emmanuel Colombo, Agnès Tallet, Jean-Marie Boher, SERC trial group
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Based on results of clinical trials, completion ALND (cALND) is frequently not performed for patients with breast conservation therapy and one or two involved sentinel nodes (SN) by micro- or macro-metastases. However, there were limitations
Externí odkaz:
https://doaj.org/article/c13f72211bf3423f91ce4844474dd13c
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Christine Tunon de Lara, Pierre Gimbergues, Tristan Gauthier, Christelle Faure-Virelizier, Véronique Vaini-Cowen, Stéphane Lantheaume, Claudia Regis, Emile Darai, Vivien Ceccato, Gauthier D’Halluin, Francesco Del Piano, Richard Villet, Eva Jouve, Bassoodéo Beedassy, Pierrick Theret, Philippe Gabelle, Cécile Zinzindohoue, Pierre Opinel, Catherine Marsollier-Ferrer, Caroline Dhainaut-Speyer, Pierre-Emmanuel Colombo, Eric Lambaudie, Agnès Tallet, Jean-Marie Boher, Others investigators (SERC trial group)
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). However, we can outline strong limitations of these trial
Externí odkaz:
https://doaj.org/article/5feb8aa57f254ca5931669b6a71b124c
Autor:
Gilles Houvenaeghel, Houssein El Hajj, Julien Barrou, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, François Desmons, Agnès Tallet, Jean-Marie Boher, the SERC Trial Group
Publikováno v:
Cancers, Vol 12, Iss 2924, p 2924 (2020)
Cancers
Volume 12
Issue 10
Cancers
Volume 12
Issue 10
Simple Summary After the results of many trials, it is now accepted to omit axillary dissection in selected patients with limited axillary involvement. However, the external validity of these trials is questionable. Our study aimed to evaluate the ac
Autor:
Sandy Lacombe, Nicolas Sterckers, Pédro Raro, Marian Gutowski, Monique Cohen, Emilie Monrigal, Gilles Houvenaeghel, Aude Michel, H. Charitansky, Frédéric Trentini, Jean-Pierre Daures, Pierre Bertrand, Cécile Zinzindohoue, Christelle Faure, Bernard Miramand
Publikováno v:
Annals of Surgical Oncology
Annals of Surgical Oncology, Springer Verlag, 2016, 23 (7), pp.2350-2356. ⟨10.1245/s10434-016-5146-y⟩
Annals of Surgical Oncology, Springer Verlag, 2016, 23 (7), pp.2350-2356. ⟨10.1245/s10434-016-5146-y⟩
International audience; BackgroundSkin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) is increasingly used in invasive breast cancer. However, adjuvant chemotherapy (CT) and radiotherapy (RT) can increase the rate of local compli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7481a940909d7e1fdb6b5f2039325c12
https://hal.archives-ouvertes.fr/hal-02916714
https://hal.archives-ouvertes.fr/hal-02916714
Autor:
Claudia Regis, Gauthier D’Halluin, A. Tallet, P.-E. Colombo, P. Guimbergues, Emile Daraï, Pierrick Theret, C. Tunon de Lara, Eva Jouve, F Del Piano, C Marsollier-Ferrer, Stéphane Lantheaume, Philippe Gabelle, R. Villet, Vivien Ceccato, Tristan Gauthier, J. de Troyer, Monique Cohen, V Di Beo, Bassoodéo Beedassy, Pierre Opinel, G. Houvenaeghel, J.M. Boher, Caroline Dhainaut-Speyer, Cécile Zinzindohoue, C. Faure, Véronique Vaini-Cowen, Eric Lambaudie, Pédro Raro
Publikováno v:
Cancer Research. 78:P3-01
Background: Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). However, we can outline strong limitations of these trials to val
Autor:
G. Houvenaeghel, C. Belichard, Pédro Raro, J. L. Houpeau, P.-F. Dupre, Frédéric Marchal, E. Barranger, Pierre Gimbergues, C Bourcier, Séverine Alran, P Deblay, V. Bordes, C. Tunon de Lara, Celine Lefebvre, C. Faure, P. Rouanet, J-M Classe
Publikováno v:
Cancer Research. 72:OT2-1
Background: Half of the patient treated with neoadjuvant chemotherapy (NAC) for a large operable breast cancer have no axillary lymph node involvement at the time of surgery. Sentinel lymph node detection (SLND), performed after NAC, would select pat
Autor:
G. Houvenaeghel, H. Charitansky, J-F Rodier, C de Lara Tunon, P.-F. Dupre, D Kere, C. Faure, J. L. Houpeau, Frédéric Marchal, J-M Classe, P De Blaye, N Andrieux, Fabrice Lecuru, Pédro Raro, Celine Lefebvre
Publikováno v:
Cancer Research. 72:P1-01
Background: Large multi institutional studies have pointed that previous surgical resection of breast tumours before axillary sentinel node detection (ASLND) was the main criteria of failure of this technique. Screening campaigns provide small tumour